Target intelligence / Profile preview

CTAGE family member 13, pseudogene (CTAGE13P)

Target
CTAGE13P
Molecular classification
Other
01

Overview

CTAGE family member 13, pseudogene (CTAGE13P), is classified as a pseudogene in the human genome[1][2]. Pseudogenes are non-functional segments of DNA that resemble functional genes but have lost their protein-coding ability or are otherwise non-functional due to mutations or genomic alterations[3]. Most pseudogenes, including CTAGE13P, do not produce functional proteins and are not considered therapeutic or pharmacological targets[1][2][3]. While some pseudogenes can be transcribed and may participate in regulatory processes (e.g., acting as competitive endogenous RNAs or modulating gene expression), there is currently no evidence that CTAGE13P plays any direct or recognized biological, disease, or therapeutic function. It is not associated with any drug interactions, safety concerns, or use as a biomarker. The record likely appears in databases solely because of its sequence similarity to functional CTAGE gene family members; however, it does not encode an active targetable product and should not be considered a molecular target in the pharmaceutical or biomedical sense[1][2][3].

Other names
CTAGE13PCTAGE family member 13, pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on CTAGE family member 13, pseudogene (CTAGE13P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTAGE family member 13, pseudogene (CTAGE13P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call